TAYLOR KEITH D 4
4 · EQUINIX INC · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Equinix (EQIX) CFO Keith D. Taylor Sells Shares
What Happened
- Keith D. Taylor, Chief Financial Officer of Equinix (EQIX), converted/ exercised derivative awards into common stock on Feb 17, 2026 and received a grant; he then sold shares in the open market on Feb 18, 2026. The filing shows conversions/exercises of 1,096, 1,111 and 2,397 shares (total 4,604) at $0.00 and a separate grant/award of 4,793 shares. On Feb 18 he sold 2,422 shares in multiple transactions for total proceeds of approximately $2,262,757 (prices roughly $926.67 to $943.86 per share; detailed weighted-average ranges are noted in the filing).
Key Details
- Transaction dates: conversions/exercises and award recorded 2026-02-17; open-market sales executed 2026-02-18; Form 4 filed 2026-02-19.
- Sales: 2,422 shares sold across multiple trades, proceeds ≈ $2,262,757; largest single reported line was 542 shares for $502,917 (weighted averages and price ranges provided in footnotes).
- Acquisition: Exercises/conversions totaled 4,604 shares (at $0.00) and an additional award of 4,793 shares was recorded; an ESPP purchase of 32.243 shares on Feb 13, 2026 is also noted (footnote F1).
- Shares owned after the transaction: not specified in the excerpt provided.
- Notable footnotes: sales were executed under a 10b5-1 trading plan to raise funds to pay withholding taxes from RSU vesting (F2); many sale prices are reported as weighted averages with ranges listed in footnotes (F3–F15); several footnotes (F16–F19) describe prior performance-RSU grants and vesting schedules.
- Timeliness: Filing dated Feb 19, 2026, which is within the typical Form 4 reporting window for the Feb 17–18 transactions.
Context
- Derivative activity labeled “M” indicates exercise/conversion of derivative awards (e.g., RSUs/PRSUs) into shares at $0.00 exercise price, per the filing. Many of the resulting shares were then sold in the open market—consistent with net-share sales to cover tax withholding following vesting, as noted in footnote F2. Sales under a 10b5-1 plan are generally pre-arranged and routine; they do not by themselves indicate a change in the insider’s view of the company.
Insider Transaction Report
Form 4
EQUINIX INCEQIX
TAYLOR KEITH D
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-17+1,096→ 25,501.3 total - Exercise/Conversion
Common Stock
2026-02-17+1,111→ 26,612.3 total - Exercise/Conversion
Common Stock
2026-02-17+2,397→ 29,009.3 total - Sale
Common Stock
[F2][F3]2026-02-18$926.67/sh−120$111,200→ 28,889.3 total - Sale
Common Stock
[F2][F4]2026-02-18$927.89/sh−542$502,917→ 28,347.3 total - Sale
Common Stock
[F2][F5]2026-02-18$928.58/sh−120$111,430→ 28,227.3 total - Sale
Common Stock
[F2][F6]2026-02-18$929.69/sh−120$111,563→ 28,107.3 total - Sale
Common Stock
[F2][F7]2026-02-18$930.55/sh−195$181,457→ 27,912.3 total - Sale
Common Stock
[F2][F8]2026-02-18$932.03/sh−125$116,503→ 27,787.3 total - Sale
Common Stock
[F2][F9]2026-02-18$934.01/sh−159$148,508→ 27,628.3 total - Sale
Common Stock
[F2][F10]2026-02-18$934.91/sh−81$75,728→ 27,547.3 total - Sale
Common Stock
[F2][F11]2026-02-18$937.43/sh−40$37,497→ 27,507.3 total - Sale
Common Stock
[F2][F12]2026-02-18$938.90/sh−252$236,603→ 27,255.3 total - Sale
Common Stock
[F2][F13]2026-02-18$939.80/sh−108$101,498→ 27,147.3 total - Sale
Common Stock
[F2][F14]2026-02-18$941.69/sh−240$226,006→ 26,907.3 total - Sale
Common Stock
[F2][F15]2026-02-18$942.68/sh−160$150,829→ 26,747.3 total - Sale
Common Stock
[F2]2026-02-18$943.86/sh−160$151,018→ 26,587.3 total - Exercise/Conversion
Restricted Stock Unit
[F16][F17]2026-02-17−1,096→ 0 totalExercise: $0.00→ Common Stock (1,096 underlying) - Exercise/Conversion
Restricted Stock Unit
[F18][F17]2026-02-17−1,111→ 1,111 totalExercise: $0.00→ Common Stock (1,111 underlying) - Award
Restricted Stock Unit
[F19][F17]2026-02-17+4,793→ 4,793 totalExercise: $0.00→ Common Stock (4,793 underlying) - Exercise/Conversion
Restricted Stock Unit
[F19][F17]2026-02-17−2,397→ 2,396 totalExercise: $0.00→ Common Stock (2,397 underlying)
Footnotes (19)
- [F1]32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.46 to $935.37 inclusive.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.35 to $937.52 inclusive.
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.40 to $939.34 inclusive.
- [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $939.45 to $940.32 inclusive.
- [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.41 to $942.41 inclusive.
- [F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.61 to $942.89 inclusive.
- [F16]On February 14, 2023, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2023. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 12, 2024, 25% will vest on February 15, 2025 and the remaining 25% will vest on February 15, 2026, subject solely to continued service.
- [F17]Restricted stock unit award expires upon reporting person's termination of service.
- [F18]On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service.
- [F19]On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service.
- [F2]Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.03 to $926.93, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 15 to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.23 to $928.21 inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.35 to $929.26 inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.36 to $930.31 inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.37 to $931.12 inclusive.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.57 to $932.39 inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.42 to $934.32 inclusive.
Signature
/s/ Samantha Lagocki, POA|2026-02-19